Indication

Pseudomonas aeruginosa bronchitis

*Pseudomonas aeruginosa* bronchitis is a localized lower respiratory tract infection characterized by acute or chronic inflammation of the bronchial airways caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa bronchitis

7 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common Pseudomonas aeruginosa bronchitis therapies.

Showing 1–7 of 7 drugs

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP PHARMACEUTI

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP/PREMIERPRO

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
APP/NOVAPLUS

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP/FRESENIUS K

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
Hospira

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa bronchitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pseudomonas aeruginosa bronchitis.

*Pseudomonas aeruginosa* bronchitis is a localized lower respiratory tract infection characterized by acute or chronic inflammation of the bronchial airways caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa*.

It primarily affects individuals with compromised respiratory defenses or structural lung disorders, such as cystic fibrosis, non-cystic fibrosis bronchiectasis, chronic obstructive pulmonary disease, or those requiring mechanical ventilation.

Pathophysiologically, the organism establishes infection through adherence to impaired mucosal epithelium and often forms robust alginate-rich biofilms that impair mucociliary clearance and evade host immunity.

Defining clinical features include persistent cough, increased production of thick and often purulent green sputum, worsening dyspnea, wheezing, and progressive airway damage in the absence of parenchymal consolidations characteristic of pneumonia.

Personalize your experience

Follow Pseudomonas aeruginosa bronchitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it